Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Duvelisib (INK1197) is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 40.00 | |
5 mg | In stock | $ 61.00 | |
10 mg | In stock | $ 85.00 | |
25 mg | In stock | $ 119.00 | |
50 mg | In stock | $ 158.00 | |
100 mg | In stock | $ 256.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 66.00 |
Description | Duvelisib (INK1197) is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. |
Targets&IC50 | PI3Kδ:23 pM(Ki), PI3Kβ:1564 pM(Ki), PI3Kγ:243 pM(Ki) |
Synonyms | INK1197, IPI-145 |
Molecular Weight | 416.86 |
Formula | C22H17ClN6O |
CAS No. | 1201438-56-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 77 mg/mL (184.7 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Duvelisib 1201438-56-3 PI3K/Akt/mTOR signaling PI3K Phosphoinositide 3-kinase INK1197 IPI-145 inhibit IPI145 INK 1197 INK-1197 Inhibitor IPI 145 inhibitor